FindTrial
Sign In

Yohimbine Hydrochloride

DRUG5 trials

Sponsors

National Institute of Mental Health (NIMH), Medical University of Vienna, Southern Methodist University, Wayne State University, Florida State University

Conditions

AutoregulationBlood Flow VelocityCannabis Use DisorderCigarette SmokingDepression, InvolutionalMajor DepresssionOcular PhysiologySocial Anxiety Disorder

Early Phase 1

Cannabinoids and Biological Reactivity to Stress
CompletedNCT06430580
Florida State UniversityCannabis Use Disorder
Start: 2024-09-30End: 2026-08-13Updated: 2026-08-20

Phase 1

Investigation of Nicotine Seeking Behavior in Current Smokers
CompletedNCT03670212
Wayne State UniversityCigarette Smoking
Start: 2016-01-07End: 2016-10-04Updated: 2018-09-13

Phase 2

Rapid Antidepressant Effects of Yohimbine in Major Depression
CompletedNCT00078715
National Institute of Mental Health (NIMH)Depression, Involutional, Major Depresssion
Start: 2004-03-31End: 2009-08-31Updated: 2019-08-29

Phase 3

Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
CompletedNCT00958880
Southern Methodist UniversitySocial Anxiety Disorder
Start: 2009-03-31End: 2013-01-31Updated: 2013-11-11

Phase 4

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery
CompletedNCT00814047
Medical University of ViennaAutoregulation, Blood Flow Velocity, Ocular Physiology
Target: 18Updated: 2008-12-23